Tear film profile in patients with active thyroid orbithopathy;Ocena stanu filmu łzowego u chorych z aktywna̧ postacia̧ orbitopatii tarczycowej

Klinika Oczna

Volumn 107, Issue 7-9, 2005, Pages 479-482

  Nowak, Mariusz ^a,b   Marek, Bogdan ^a   Kos Kudła, Beata ^a   Kajdaniuk, Dariusz ^a   Siemińska, Lucyna ^a  

^a AM   (Poland)

^b AM w Katowicach   (Poland)

Author keywords

Dry eye; Tear film profile; Thyroid orbitopathy

Indexed keywords

DYE; FLUORESCEIN;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRY EYE; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; STAINING; TEAR FILM; FEMALE; HOSPITALIZATION; LACRIMAL APPARATUS; LACRIMAL FLUID; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; THYROID GLAND;

DRY EYE SYNDROMES; FEMALE; GRAVES DISEASE; HUMANS; LACRIMAL APPARATUS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TEARS; THYROID GLAND;

EID: 33645915444     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bartalena L., Pinchera A., Marcocci C.: Management of Graves' ophthalmopathy: reality and perspectives. Endocr. Rev., 2000, 21, 168-199.
2. Gilbard J. P., Farris R. L.: Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol., 1983, 61, 108-116.
3. Grus F. H., Augustin A. J.: High performance liquid chromatography analysis of tear protein patterns in diabetic and non-diabetic dry-eye patients. Eur. J. Ophthalmol., 2001, 11, 19-24.
4. Heufelder A. E.: Pathogenesis of ophthalmopathy in autoimmune thyroid disease. Rev. Endocr. Metab. Disord., 2000, 1 (1-2), 87-95.
5. Khalil H. A., de Keizer R. J. W., Kijlstra A.: Analysis of tear proteins in Graves' ophthalmopathy. High Performance Liquid Chromatography. Am. J. Ophthalmol., 1988, 106, 186-190.
6. Korb D. R.: Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea, 2000, 19, 483-486.
7. Lemp M. A.: Epidemiology and classification of dry eye. Adv. Exp. Med. Biol., 1998, 438, 791-803.
8. Moss S. E., Klein R., Klein B. E.: Prevalence of and risk factors for dry eye syndrome. Arch. Ophthalmol., 2000, 118, 1264-1268.
9. Mourits M. P., Koornneef L., Wiersinga W. M., Prummel M. F., Berghout A., van der Gaag R.: Clinical criteria for the assessment odf disease activity in Graves' opthalmopathy: a novel approach. Br. J. Ophthalmol., 1989, 73, 639-644.
10. Myśliwiec J., Krȩtkowski A., Szelachowska M., Mikita A., Kinalska I.: Serum pro- and anti-inflamatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids. Rocz. Akad. Med. Bialymst, 1999, 44, 160-169.
11. Nichols K. K., Nichols J. J., Zadnik K.: Frequency of dry eye diagnostic test procedures used in various models of ophthalmic practice. Cornea, 2000, 19, 483-486.
12. Nowak M., Kos-Kudła B.: Oftalmopatia tarczycowa Gravesa i Basedowa - patogeneza, objawy i wybrane aspekty leczenia. Klin. Oczna, 2000, 102 (6), 455-460.
13. Nowak M., Kos-Kudła B., Marek B., Świȩtochowska E., Kajdaniuk D., Szapska B., Głogowska-Szela̧j J., Siemińska L., Ostrowska Z.: Stȩżenie hormonu wzrostu (GH), insulinopodobnego czynnika wzrostu-I (IGF-I) oraz białka wia̧ża̧cego insulinopodobne czynniki wzrostowe-3 (IGFBP-3) we krwi u chorych z czynna̧ postacia̧. orbitopatii tarczycowej przed oraz po leczeniu metyloprednisolonem. Endokrynol. Pol., 2003, 2 (54), 169-174,
14. Perlmutter J. C., Burde R. M., Gado M., Roper-Hall G.: Endocrine ophthalmopathy: a disease wearing many masks. Neuro-ophthalmology, 1997, 9, 160-176.
15. Pinchera A., Wiersinga W. M., Glinoer D.: Classification of the eye changes of Graves' disease. Thyroid, 1992, 2, 235-236.